Tetranectin as a Novel Obesity-associated Adipokine for Regulating Lipid Accumulation

CompletedOBSERVATIONAL
Enrollment

289

Participants

Timeline

Start Date

December 6, 2005

Primary Completion Date

December 5, 2008

Study Completion Date

December 5, 2008

Conditions
ObesityMetabolic Syndrome
Interventions
GENETIC

Tetranectin

Adipose tissues were obtained from the breast of breast cancer patients with 0 to 1 progression stage. The subjects were 33-51 y of age (mean = 43.6, SD = 6.2) with a BMI of 16-33 kg/m2 (mean = 21.5, SD = 4.5). Blood samples were collected after an overnight fasting. Serum was separated by centrifugation and stored at -80 ℃ until analysis. Plasma Tetranectin,triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), cholesterol, glucose and insulin were measured. And the tetranectin mRNA and protein level was measure in adipose tissue

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT03229044 - Tetranectin as a Novel Obesity-associated Adipokine for Regulating Lipid Accumulation | Biotech Hunter | Biotech Hunter